vs

Side-by-side financial comparison of Fortress Biotech, Inc. (FBIO) and La Rosa Holdings Corp. (LRHC). Click either name above to swap in a different company.

La Rosa Holdings Corp. is the larger business by last-quarter revenue ($20.2M vs $16.1M, roughly 1.3× Fortress Biotech, Inc.). Fortress Biotech, Inc. runs the higher net margin — -24.5% vs -27.4%, a 2.9% gap on every dollar of revenue. On growth, Fortress Biotech, Inc. posted the faster year-over-year revenue change (6.3% vs 3.2%). Over the past eight quarters, La Rosa Holdings Corp.'s revenue compounded faster (72.5% CAGR vs 11.0%).

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.

FBIO vs LRHC — Head-to-Head

Bigger by revenue
LRHC
LRHC
1.3× larger
LRHC
$20.2M
$16.1M
FBIO
Growing faster (revenue YoY)
FBIO
FBIO
+3.1% gap
FBIO
6.3%
3.2%
LRHC
Higher net margin
FBIO
FBIO
2.9% more per $
FBIO
-24.5%
-27.4%
LRHC
Faster 2-yr revenue CAGR
LRHC
LRHC
Annualised
LRHC
72.5%
11.0%
FBIO

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
FBIO
FBIO
LRHC
LRHC
Revenue
$16.1M
$20.2M
Net Profit
$-3.9M
$-5.5M
Gross Margin
66.1%
8.4%
Operating Margin
-28.8%
-24.7%
Net Margin
-24.5%
-27.4%
Revenue YoY
6.3%
3.2%
Net Profit YoY
41.8%
-125.7%
EPS (diluted)
$-0.15
$-5.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBIO
FBIO
LRHC
LRHC
Q4 25
$16.1M
Q3 25
$17.6M
$20.2M
Q2 25
$16.4M
$23.2M
Q1 25
$13.1M
$17.5M
Q4 24
$15.1M
$17.7M
Q3 24
$14.6M
$19.6M
Q2 24
$14.9M
$19.1M
Q1 24
$13.0M
$13.1M
Net Profit
FBIO
FBIO
LRHC
LRHC
Q4 25
$-3.9M
Q3 25
$5.8M
$-5.5M
Q2 25
$15.5M
$78.4M
Q1 25
$-10.6M
$-95.7M
Q4 24
$-6.8M
$-5.1M
Q3 24
$-12.9M
$-2.5M
Q2 24
$-10.9M
$-2.3M
Q1 24
$-15.4M
$-4.6M
Gross Margin
FBIO
FBIO
LRHC
LRHC
Q4 25
66.1%
Q3 25
67.4%
8.4%
Q2 25
69.9%
8.0%
Q1 25
63.5%
8.8%
Q4 24
69.1%
8.9%
Q3 24
69.4%
8.3%
Q2 24
61.6%
8.3%
Q1 24
53.9%
8.9%
Operating Margin
FBIO
FBIO
LRHC
LRHC
Q4 25
-28.8%
Q3 25
-38.6%
-24.7%
Q2 25
-222.2%
-10.6%
Q1 25
-169.9%
-26.7%
Q4 24
-158.3%
-17.1%
Q3 24
-151.0%
-8.9%
Q2 24
-186.5%
-9.7%
Q1 24
-280.6%
-35.0%
Net Margin
FBIO
FBIO
LRHC
LRHC
Q4 25
-24.5%
Q3 25
33.2%
-27.4%
Q2 25
94.4%
337.8%
Q1 25
-80.6%
-546.5%
Q4 24
-44.7%
-28.7%
Q3 24
-88.0%
-12.5%
Q2 24
-73.5%
-12.2%
Q1 24
-118.3%
-35.1%
EPS (diluted)
FBIO
FBIO
LRHC
LRHC
Q4 25
$-0.15
Q3 25
$0.11
$-5.44
Q2 25
$0.45
$15.25
Q1 25
$-0.48
$-5.86
Q4 24
$-0.16
$28.54
Q3 24
$-0.76
$-16.49
Q2 24
$-0.73
$-12.49
Q1 24
$-1.04
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBIO
FBIO
LRHC
LRHC
Cash + ST InvestmentsLiquidity on hand
$79.4M
$4.0M
Total DebtLower is stronger
$52.4M
$642.8K
Stockholders' EquityBook value
$49.9M
$1.6M
Total Assets
$185.5M
$21.7M
Debt / EquityLower = less leverage
1.05×
0.41×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBIO
FBIO
LRHC
LRHC
Q4 25
$79.4M
Q3 25
$86.2M
$4.0M
Q2 25
$74.4M
$5.1M
Q1 25
$91.3M
$2.9M
Q4 24
$57.3M
$1.4M
Q3 24
$58.9M
$1.8M
Q2 24
$76.2M
$1.6M
Q1 24
$83.8M
$1.1M
Total Debt
FBIO
FBIO
LRHC
LRHC
Q4 25
$52.4M
Q3 25
$47.8M
$642.8K
Q2 25
$50.0M
$644.3K
Q1 25
$56.4M
$645.9K
Q4 24
$58.0M
$647.6K
Q3 24
$52.5M
$649.2K
Q2 24
$67.0M
$650.8K
Q1 24
$61.4M
$652.4K
Stockholders' Equity
FBIO
FBIO
LRHC
LRHC
Q4 25
$49.9M
Q3 25
$55.9M
$1.6M
Q2 25
$43.9M
$3.4M
Q1 25
$22.3M
$-87.5M
Q4 24
$22.7M
$2.6M
Q3 24
$21.2M
$5.0M
Q2 24
$17.9M
$4.7M
Q1 24
$23.0M
$5.6M
Total Assets
FBIO
FBIO
LRHC
LRHC
Q4 25
$185.5M
Q3 25
$181.4M
$21.7M
Q2 25
$159.9M
$22.9M
Q1 25
$178.1M
$21.0M
Q4 24
$144.2M
$19.4M
Q3 24
$127.1M
$19.7M
Q2 24
$145.7M
$18.7M
Q1 24
$164.6M
$16.3M
Debt / Equity
FBIO
FBIO
LRHC
LRHC
Q4 25
1.05×
Q3 25
0.86×
0.41×
Q2 25
1.14×
0.19×
Q1 25
2.53×
Q4 24
2.55×
0.25×
Q3 24
2.48×
0.13×
Q2 24
3.75×
0.14×
Q1 24
2.67×
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBIO
FBIO
LRHC
LRHC
Operating Cash FlowLast quarter
$-12.5M
$-1.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBIO
FBIO
LRHC
LRHC
Q4 25
$-12.5M
Q3 25
$-6.1M
$-1.3M
Q2 25
$-27.6M
$-1.4M
Q1 25
$-19.6M
$-3.5M
Q4 24
$-12.9M
$-1.1M
Q3 24
$-20.1M
$-591.6K
Q2 24
$-21.8M
$-803.1K
Q1 24
$-25.4M
$-538.3K
Capex Intensity
FBIO
FBIO
LRHC
LRHC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
Q1 24
Cash Conversion
FBIO
FBIO
LRHC
LRHC
Q4 25
Q3 25
-1.04×
Q2 25
-1.78×
-0.02×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FBIO
FBIO

Segment breakdown not available.

LRHC
LRHC

Real Estate Residential Brokerage Services$16.8M83%
Transferred Over Time$3.5M17%

Related Comparisons